Skin collagen enhancing agent
US-9522109-B2 · Dec 20, 2016 · US
US11207258B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11207258-B2 |
| Application number | US-201716072330-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 25, 2017 |
| Priority date | Jan 25, 2016 |
| Publication date | Dec 28, 2021 |
| Grant date | Dec 28, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
It is an object of the present invention to provide a capsule comprising a functional substance and having good shape stability and a good feeling of use. A method for producing a capsule, comprising steps of mixing gelatin and a functional substance; adding a carbodiimide crosslinking agent to crosslink the gelatin with the carbodiimide crosslinking agent; solidifying the crosslinked gelatin; and grinding the solidified gelatin.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a capsule, comprising steps of: mixing gelatin and a functional substance, wherein the gelatin has a jelly strength of 110 g to 180 g, and wherein the functional substance has a water solubility of 10 g/L or less, and is selected from the group consisting of: a lignan, a catechin, a flavonol, an anthocyanin, an isoflavone, ferulic acid, and ellagic acid; crosslinking the gelatin by only reacting with a carbodiimide crosslinking agent; solidifying the crosslinked gelatin; and grinding the solidified gelatin to obtain the capsule. 2. The production method according to claim 1 , wherein the gelatin is crosslinked in a solution comprising the carbodiimide crosslinking agent at a concentration of 5 mM to 200 mM. 3. The production method according to claim 1 , wherein the gelatin and the carbodiimide crosslinking agent are reacted at a concentration ratio of 1:0.06 to 1:0.2. 4. The production method according to claim 1 , wherein the carbodiimide crosslinking agent is selected from the group consisting of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, 1-cyclohexyl-3-(2-morpholinyl-4-ethyl)carbodiimide, dicyclohexylcarbodiimide, diisopropylcarbodiimide, and salts thereof. 5. A capsule comprising (i) a functional substance and (ii) gelatin crosslinked only by reacting with a carbodiimide crosslinking agent, wherein the functional substance has a water solubility of 10 g/L or less, and is selected from the group consisting of: a lignan, a catechin, a flavonol, an anthocyanin, an isoflavone, ferulic acid, and ellagic acid, and wherein the gelatin has a jelly strength of 110 g to 180 g. 6. The capsule according to claim 5 , wherein the gelatin has a jelly strength of 135 g to 165 g. 7. The capsule according to claim 5 , wherein the gelatin is acid-treated gelatin. 8. The capsule according to claim 5 , wherein the functional substance is sesamin or ferulic acid.
Polymerisation; cross-linking · CPC title
derived from leather or skin · CPC title
Shaping or working of foodstuffs characterised by the products · CPC title
Polysaccharides · CPC title
After-treatment of capsule walls, e.g. hardening · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.